Cutler Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$215K Sell
3,140
-1,247
-28% -$80.2K 0.07% 266
2023
Q4
$253K Buy
+4,387
New +$234K 0.02% 645
2023
Q3
Sell
-911
Closed -$47.8K 3813
2023
Q2
$49K Buy
911
+479
+111% +$25K 0.01% 1294
2023
Q1
$21K Sell
432
-4,957
-92% -$234K ﹤0.01% 1887
2022
Q4
$249K Buy
+5,389
New +$233K 0.02% 681
2022
Q3
Sell
-383
Closed -$15.4K 4930
2022
Q2
$14K Sell
383
-2,108
-85% -$85.8K ﹤0.01% 2934
2022
Q1
$110K Buy
2,491
+2,088
+518% +$90.5K 0.01% 1623
2021
Q4
$17K Sell
403
-127
-24% -$5.34K ﹤0.01% 3238
2021
Q3
$22K Sell
530
-465
-47% -$20.6K ﹤0.01% 3256
2021
Q2
$42K Buy
995
+395
+66% +$16.6K ﹤0.01% 2631
2021
Q1
$23K Sell
600
-5,400
-90% -$204K ﹤0.01% 3086
2020
Q4
$215K Buy
6,000
+2,500
+71% +$90.1K 0.01% 1048
2020
Q3
$133K Buy
3,500
+1,900
+119% +$73.2K 0.01% 1140
2020
Q2
$56K Buy
+1,600
New +$57.6K ﹤0.01% 1668
2018
Q3
Sell
-5,500
Closed -$179K 4112
2018
Q2
$179K Buy
5,500
+2,500
+83% +$75.4K 0.01% 827
2018
Q1
$81K Buy
3,000
+2,700
+900% +$73.4K 0.01% 1337
2017
Q4
$7K Hold
300
﹤0.01% 3369
2017
Q3
$8K Hold
300
﹤0.01% 3966
2017
Q2
$8K Buy
300
+100
+50% +$2.65K ﹤0.01% 4343
2017
Q1
$4K Sell
200
-37,800
-99% -$919K ﹤0.01% 4854
2016
Q4
$821K Sell
38,000
-600
-2% -$13.1K 0.03% 479
2016
Q3
$918K Sell
38,600
-2,500
-6% -$59.6K 0.04% 367
2016
Q2
$960K Sell
41,100
-35,373
-46% -$765K 0.05% 300
2016
Q1
$1.44M Buy
+76,473
New +$1.34M 0.09% 183

Other funds holding BSX

Cutler Group's BSX Position: Q1 2024 in Review

Cutler Group reduced its Boston Scientific (BSX) stake by 28% in Q1 2024, selling an estimated $80.2K and leaving 3,140 shares worth $215K. The position accounts for 0.07% of the portfolio, ranked #266.

Cutler Group first reported a position in BSX in Q1 2016 and has held it in 24 quarters since. The position peaked at $1.44M in Q1 2016. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Cutler Group held 3,140 shares of Boston Scientific worth $215K as of Q1 2024.
  • Cutler Group sold 1,247 Boston Scientific shares in Q1 2024, an estimated $80.2K.
  • Boston Scientific made up 0.07% of Cutler Group's portfolio in Q1 2024, its #266 holding.
  • Cutler Group first reported a position in Boston Scientific in Q1 2016 and has held it in 24 quarters since.
  • Cutler Group's Boston Scientific position peaked at $1.44M in Q1 2016.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.